UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 100

Sortiert nach

The effects of oral and vaporized cannabis alone, and in combination with alcohol, on driving performance using the STISIM driving simulator: A two-part, double-blind, double-dummy, placebo-controlled, randomized crossover clinical laboratory protocol

Frontiers in pharmacology, 2022-09, Vol.13, p.964749

2022

Volltextzugriff (PDF)

Gut microbiome and metabolome in a non-human primate model of chronic excessive alcohol drinking

Translational psychiatry, 2021-12, Vol.11 (1), p.609-609, Article 609

2021

Volltextzugriff (PDF)

Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations

Psychopharmacology, 2022-05, Vol.239 (5), p.1397-1408

2022

Volltextzugriff (PDF)

Oxytocin for the treatment of drug and alcohol use disorders

Behavioural pharmacology, 2016-12, Vol.27 (8), p.640

2016

Volltextzugriff (PDF)

Sex Differences in Cannabis Withdrawal Symptoms Among Treatment-Seeking Cannabis Users

Experimental and clinical psychopharmacology, 2015-12, Vol.23 (6), p.415-421

2015

Volltextzugriff (PDF)

Sex differences in the acute effects of oral and vaporized cannabis among healthy adults

Addiction biology, 2021-07, Vol.26 (4), p.e12968-n/a

2021

Volltextzugriff (PDF)

GABRA2 markers moderate the subjective effects of alcohol

Addiction biology, 2013-03, Vol.18 (2), p.357-369

2013

Volltextzugriff (PDF)

Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users

Drug and alcohol dependence, 2020-06, Vol.211, p.107937-107937, Article 107937

2020

Volltextzugriff (PDF)

Oral Cannabidiol does not alter Alcohol Seeking and Self‐Administration in Baboons

Drug and alcohol dependence, 2023-04, Vol.245, p.109829-109829, Article 109829

2023

Volltextzugriff (PDF)

Evaluation of Cytochrome P450‐Mediated Cannabinoid‐Drug Interactions in Healthy Adult Participants

Clinical pharmacology and therapeutics, 2023-09, Vol.114 (3), p.693-703

2023

Volltextzugriff (PDF)

Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence

The Journal of pharmacology and experimental therapeutics, 2019-11, Vol.371 (2), p.422

2019

Volltextzugriff (PDF)

Effects of Oral Δ9-Tetrahydrocannabinol and Cannabidiol Combinations on a Sustained Attention Task in Rats

Experimental and clinical psychopharmacology, 2023-10, Vol.31 (5), p.881-887

2023

Volltextzugriff (PDF)

Translational models of cannabinoid vapor exposure in laboratory animals

Behavioural pharmacology, 2022-04, Vol.33 (2&3), p.63

2022

Volltextzugriff (PDF)

Evaluation of Mifepristone Effects on Alcohol-Seeking and Self-Administration in Baboons

Experimental and clinical psychopharmacology, 2019-06, Vol.27 (3), p.227-235

2019

Volltextzugriff (PDF)

Appetitive, antinociceptive, and hypothermic effects of vaped and injected Δ-9-tetrahydrocannabinol (THC) in rats: exposure and dose-effect comparisons by strain and sex

Pharmacology, biochemistry and behavior, 2021-03, Vol.202, p.173116-173116, Article 173116

2021

Volltextzugriff (PDF)

Development of a novel alcohol and nicotine concurrent access (ANCA) self-administration procedure in baboons

Drug and alcohol dependence, 2020-01, Vol.206, p.107665-107665, Article 107665

2020

Volltextzugriff (PDF)

The Effects of Varenicline on Alcohol Seeking and Self-Administration in Baboons

Alcoholism, clinical and experimental research, 2014-02, Vol.38 (2), p.376-383

2014

Volltextzugriff (PDF)

Brain imaging of cannabinoid type I (CB1) receptors in women with cannabis use disorder and male and female healthy controls

Addiction biology, 2021-11, Vol.26 (6), p.e13061-n/a

2021

Volltextzugriff (PDF)

A Double-Blind, Randomized, Placebo-Controlled, Pilot Clinical Trial Examining Buspirone as an Adjunctive Medication During Buprenorphine-Assisted Supervised Opioid Withdrawal

Experimental and clinical psychopharmacology, 2023-02, Vol.31 (1), p.194-203

2023

Volltextzugriff (PDF)

A cross-sectional survey on cannabis: Characterizing motives, opinions, and subjective experiences associated with the use of various oral cannabis products

Drug and alcohol dependence, 2023-04, Vol.245, p.109826-109826, Article 109826

2023

Volltextzugriff (PDF)

A paradigm for examining stress effects on alcohol‐motivated behaviors in participants with alcohol use disorder

Addiction biology, 2018-03, Vol.23 (2), p.836-845

2018

Volltextzugriff (PDF)

Brain PET Imaging of α7-nAChR with [18F]ASEM: Reproducibility, Occupancy, Receptor Density, and Changes in Schizophrenia

The international journal of neuropsychopharmacology, 2018-07, Vol.21 (7), p.656-667

2018

Volltextzugriff (PDF)

Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial

JAMA network open, 2023-02, Vol.6 (2), p.e2254752

2023

Volltextzugriff (PDF)

Preliminary evidence of different and clinically meaningful opioid withdrawal phenotypes

Addiction biology, 2020-01, Vol.25 (1), p.e12680-n/a

2020

Volltextzugriff (PDF)

GABAB Receptors and Alcohol Use Disorders: Preclinical Studies

Behavioral Neurobiology of GABAB Receptor Function, 2022, Vol.52, p.157-194

2022

Volltextzugriff (PDF)

1 – 25 von 100

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(91)

Publikationsform

Artikel
(97)
Buchkapitel
(3)

Sprache

Englisch
(100)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The effects of oral and vaporized cannabis alone, and in combination with alcohol, on driving performance using the STISIM driving simulator: A two-part, double-blind, double-dummy, placebo-controlled, randomized crossover clinical laboratory protocol

Gut microbiome and metabolome in a non-human primate model of chronic excessive alcohol drinking

Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations

Oxytocin for the treatment of drug and alcohol use disorders

Sex Differences in Cannabis Withdrawal Symptoms Among Treatment-Seeking Cannabis Users

Sex differences in the acute effects of oral and vaporized cannabis among healthy adults

GABRA2 markers moderate the subjective effects of alcohol

Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users

Oral Cannabidiol does not alter Alcohol Seeking and Self‐Administration in Baboons

Evaluation of Cytochrome P450‐Mediated Cannabinoid‐Drug Interactions in Healthy Adult Participants

Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence

Effects of Oral Δ9-Tetrahydrocannabinol and Cannabidiol Combinations on a Sustained Attention Task in Rats

Translational models of cannabinoid vapor exposure in laboratory animals

Evaluation of Mifepristone Effects on Alcohol-Seeking and Self-Administration in Baboons

Appetitive, antinociceptive, and hypothermic effects of vaped and injected Δ-9-tetrahydrocannabinol (THC) in rats: exposure and dose-effect comparisons by strain and sex

Development of a novel alcohol and nicotine concurrent access (ANCA) self-administration procedure in baboons

The Effects of Varenicline on Alcohol Seeking and Self-Administration in Baboons

Brain imaging of cannabinoid type I (CB1) receptors in women with cannabis use disorder and male and female healthy controls

A Double-Blind, Randomized, Placebo-Controlled, Pilot Clinical Trial Examining Buspirone as an Adjunctive Medication During Buprenorphine-Assisted Supervised Opioid Withdrawal

A cross-sectional survey on cannabis: Characterizing motives, opinions, and subjective experiences associated with the use of various oral cannabis products

A paradigm for examining stress effects on alcohol‐motivated behaviors in participants with alcohol use disorder

Brain PET Imaging of α7-nAChR with [18F]ASEM: Reproducibility, Occupancy, Receptor Density, and Changes in Schizophrenia

Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial

Preliminary evidence of different and clinically meaningful opioid withdrawal phenotypes

GABAB Receptors and Alcohol Use Disorders: Preclinical Studies

Suchergebnisse filtern